Gameto Raises $44M for Phase 3 Stem Cell Reproductive Care Trial
August 15, 2025
No Comments
The Series C funding enables Gameto to complete the ongoing Phase 3 trial for its lead program, Fertilo, and file for regulatory approvals globally. Fertilo
